Business Insights, June 2011, Pages: 187
Advancing MolecularDiagnostics to Personalize Cancer Therapy This report analyzes current and potential world markets for key cancer-based moleculardiagnostics, including advances in the field
Global Industry Analysts, Inc., Oct 2010, Pages: 659
with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 147
Table 7: World Historic Review for MolecularDiagnostics by
Geographic Region - US, Canada
TriMark Publications, May 2011, Pages: 3057
Diagnostics in Cancer Testing
- MolecularDiagnostics in Infectious Disease Testing
- MolecularDiagnostics Markets
- Over-the-Counter Diagnostic Products World Markets
- Point of Care Diagnostic Testing Sector
Fuji-Keizai USA, Inc., May 2007, Pages: 163
MolecularDiagnostics 2007: Technologies, Companies, Products, Applications and WW Outlook This report reviews, analyzes and sizes the combined moleculardiagnostics product and clinical lab services
DeciBio, Feb 2012, Pages: 117
MolecularDiagnostics: Market Segmentation and Opportunities - 4th Edition Moleculardiagnostics (MDx) are a class of in vitro diagnostic (IVD) tests that identify nucleic acids, such as DNA. MDx
Takeda Pacific, April 2012, Pages: 171
Medical)
-Agendia BV
-Roche MolecularDiagnostics
-Next Generation Sequencers for Personalized Medicine
-Clinical Next Gen. Sequencing Market Size and Major Makers
-Illumina
-Roche 454
-Life Technologies
Fuji-Keizai USA, Inc., May 2007, Pages: 163
MolecularDiagnostics 2007: Technologies, Companies, Products, Applications and WW Outlook This report reviews, analyzes and sizes the combined moleculardiagnostics product and clinical lab services
Global Industry Analysts, Inc., Jan 2011, Pages: 448
for Years 2007 through 2015 (includes
corresponding Graph/Chart) 70
Table 2: World Historic Review for DNA Probes-based
Diagnostics by Geographic
Takeda Pacific, July 2005, Pages: 168
Pricey MolecularDiagnostics
Developing World Needs Diagnostics Too
Fastest Regulatory Route to Commercializing Tests
Roche and Affymetrix First to Get Clearance to Market
Microarray-Based
Fuji-Keizai USA, Inc., Aug 2010, Pages: 155
. The market is segmented by major product and service areas by disease, by major technology and by major world regions to see the growth opportunity.
This study reviews and analyzes major company alliances and M&As during
Fuji-Keizai USA, Inc., Aug 2010, Pages: 171
. The market is segmented by major product and service areas by disease, by major technology and by major world regions to see the growth opportunity.
This study reviews and analyzes major company alliances and M&As during
Venture Planning Group, April 2012, Pages: 1900
the world's major health threat and a major factor contributing to the rise in incidence of opportunistic infections; bioterrorism; advances in moleculardiagnostic technologies; and a wider availability
TriMark Publications, May 2011, Pages: 1784
- Cytology and HPV Testing World Markets
- MolecularDiagnostics in Cancer Testing
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
Until superior therapeutic treatments are developed
TriMark Publications, Feb 2012, Pages: 214
to a known drug therapy. This linkage could be important in the therapeutic application and clinical outcome of a drug, such as with personalized medicine for oncology patients. The moleculardiagnostics field
Global Industry Analysts, Inc., Oct 2011, Pages: 373
Analyzed with Annual Sales
in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) 64
Table 8: World Historic Review for Diagnostic
Radiopharmaceuticals by Geographic Region
Global Industry Analysts, Inc., Aug 2011, Pages: 239
: World Historic Review for Molecular Cytogenetics
Technologies by Geographic Region - North America, Europe, and
Rest of World Independently Analyzed with Annual Sales Figures
in US$ Thousand for Years
Global Industry Analysts, Inc., Feb 2011, Pages: 477
for Years 2007 through
2015 (includes corresponding Graph/Chart) 102
Table 12: World Historic Review for Cardiovascular Disease
Diagnostics by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific
Venture Planning Group, Nov 2011, Pages: 1900
the world's major health threat and a major factor contributing to the rise in incidence of opportunistic infections; bioterrorism; advances in moleculardiagnostic technologies; and a wider availability
Renub Research, Feb 2011, Pages: 60
MolecularDiagnostics, Genomics and Proteomics and Consumer Self Diagnostic markets data from 2006 to 2015 has been analyzed in this report. From technology point of view segments like MolecularDiagnostics
